Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Marston's on track to deliver full-year profit in line with expectations

(Sharecast News) - Marston's said in an update on Tuesday that it was on track to deliver full-year profit before tax in line with market expectations, as second-half trading momentum and strategic progress continue to build. The London-listed pub operator said that it saw like-for-like sales growth of 2.9% for the most recent 15-week period, despite a tough comparison with last year's Euro 2024 boost.

Excluding England matchdays from the prior year, sales were up 4%.

Year-to-date like-for-like sales now stood 2% higher.

The company said margin expansion initiatives remained on course, supported by improvements in revenue management, labour controls, and procurement.

Marston's also highlighted the success of its pub refurbishment programme, with 26 sites already operating under new formats - 21 as Two Door and five as Grandstand locations.

A further five Woodie's Family Pubs were expected to open by the end of July, putting the company ahead of its target of 30 format conversions for the year.

Capital expenditure was expected to total around £60m, in line with prior guidance, as the group continued to invest in its estate, digital transformation, and guest experience.

"We're excited about the momentum we're building throughout the business, with our performance enhanced by a strong pipeline of demand-driving events, continued growth from Order & Pay and our ongoing revenue management initiatives," said chief executive Justin Platt.

"We've made excellent progress against our strategic priorities so far this year, delivering improved margin performance, strong cash generation and the roll-out of our new pub formats.

"This momentum and our disciplined execution across the business gives us great confidence for the future, and we remain firmly on-track to deliver on full-year market expectations."

At 1051 BST, shares in Marston's were down 3.5% at 42.46p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.